Researchers at University of Toulouse Target Ovarian Cancer (PPARg activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression).

Předmět:	TUMOR growth OVARIAN tumors OVARIAN cancer MACROPHAGES CONNECTIVE tissue cells IMMUNOSUPPRESSION
Zdroj:	Women's Health Weekly; 8/29/2023, p2196-2196, 1p
Abstrakt:	Keywords: Ascites; Cancer; Connective Tissue Cells; Drugs and Therapies; Gynecology; Health and Medicine; Immunology; Immunosuppression; Macrophages; Mononuclear Phagocyte System; Myeloid Cells; Oncology; Ovarian Cancer; Phagocytes; Risk and Prevention; Women's Health EN Ascites Cancer Connective Tissue Cells Drugs and Therapies Gynecology Health and Medicine Immunology Immunosuppression Macrophages Mononuclear Phagocyte System Myeloid Cells Oncology Ovarian Cancer Phagocytes Risk and Prevention Women's Health 2196 2196 1 08/28/23 20230829 NES 230829 2023 SEP 1 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A new study on ovarian cancer is now available. For more information on this research see: PPARg activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu